Covid-19 « Science and Enterprise

Trial Assessing Digital Data for Covid-19 Vaccine Responses

By Alan, on March 17th, 2022%

A clinical trial is evaluating data gleaned from wearable devices for measuring individual physiological reactions to Covid-19 vaccines. . . . → Read More: Trial Assessing Digital Data for Covid-19 Vaccine Responses

Infographic – Covid-19 Deaths Shift to GOP Areas

By Alan, on March 5th, 2022%

Data show regions of the U.S. voting more strongly for Donald Trump in 2020 are now bearing the main brunt of Covid-19 deaths. . . . → Read More: Infographic – Covid-19 Deaths Shift to GOP Areas

Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load

By Alan, on March 3rd, 2022%

Tests with lab animals show a vaccine given as a nasal spray produces high antibody volumes against SARS-CoV-2 infections and reduces viral loads. . . . → Read More: Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load

Trial Begins for Advanced Covid-19 Disease Anti-Viral

By Alan, on February 15th, 2022%

A late-stage clinical trial is underway testing an oral anti-viral drug to treat moderate to severe cases of Covid-19 infections. . . . → Read More: Trial Begins for Advanced Covid-19 Disease Anti-Viral

Synthetic SARS-CoV-2 Particle Designed for Drug R&D

By Alan, on February 7th, 2022%

Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers. . . . → Read More: Synthetic SARS-CoV-2 Particle Designed for Drug R&D

Science/Tech AI Developer Raises $100M in New Funds

By Alan, on January 25th, 2022%

A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round. . . . → Read More: Science/Tech AI Developer Raises $100M in New Funds

Group Devising Lower Cost Clinical Trials

By Alan, on January 24th, 2022%

A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost. . . . → Read More: Group Devising Lower Cost Clinical Trials

Infographic – Cyber Incidents Top 2022 Business Risks

By Alan, on January 22nd, 2022%

An international survey shows more risk management experts consider cyber incidents the leading global risk to business in 2022. . . . → Read More: Infographic – Cyber Incidents Top 2022 Business Risks

Exosomes Shown to Block Broad Covid-19 Variant Range

By Alan, on January 20th, 2022%

Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range

Trial Shows Gut Probiotic Reduces Covid-19 Disease

By Alan, on January 12th, 2022%

Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease. . . . → Read More: Trial Shows Gut Probiotic Reduces Covid-19 Disease

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise